GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 18.81
-0.58 (-2.99%)
At close: Jun 1, 2026
GemPharmatech Market Cap
GemPharmatech has a market cap or net worth of 7.69 billion as of June 1, 2026. Its market cap has increased by 64.33% in one year.
Market Cap
7.69B
Enterprise Value
6.87B
Revenue
830.61M
Ranking
n/a
PE Ratio
46.93
Stock Price
18.81
Market Cap Chart
Since April 25, 2022, GemPharmatech's market cap has increased from 7.59B to 7.69B, an increase of 1.42%. That is a compound annual growth rate of 0.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 7.93B | 25.92% |
| Dec 31, 2025 | 6.30B | 19.98% |
| Dec 31, 2024 | 5.25B | -36.47% |
| Dec 29, 2023 | 8.26B | -16.22% |
| Dec 30, 2022 | 9.86B | 30.00% |
| Apr 25, 2022 | 7.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 8.32B |
| Jiangxi Fushine Pharmaceutical | 8.24B |
| Aurisco Pharmaceutical | 8.00B |
| Bio-Thera Solutions | 7.94B |
| Youcare Pharmaceutical Group | 7.92B |
| Zhejiang Ausun Pharmaceutical | 7.85B |
| Shanghai Medicilon | 7.85B |
| Beijing Hotgen Biotech | 7.79B |